There were 3 patients with oligodendroglioma (1.3%; one with grade 2 and two with grade 3); 11 patients with IDH-mutant astrocytoma (4.9%; seven with grade 2, one with grade 3, and three with grade 4); 200 patients with IDH-wildtype astrocytoma (88.5%; two with grade 2, 19 grade 3, and 179 grade 4), and 12 patients with H3 K27M-altered diffuse midline glioma (6.3%). The gene discussed is IDH2; the disease is oligodendroglioma.